CRDL
CRDL
NASDAQ · Pharmaceuticals

Cardiol Therapeutics Inc-A

$1.32
+0.02 (+1.54%)
As of May 10, 10:38 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,739.4% upside
Low Target $16.80
Average Target $24.28
High Target $33.59
Current Price $1.32
Current
$1.32
Target
$24.28
$16.80 $24.28 avg $33.59
Scenario Analysis
Bear Case
$16.80
1,172.7%
Low target
Base Case
$24.28
+1,739.4%
Avg target
Bull Case
$33.59
+2,444.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.33
-43.3% from high
52-Week Low
$1.23
+7.8% from low
Target vs 52W High
$24.28
+942.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%